Smart for Life (SMFL) Competitors $0.01 0.00 (0.00%) As of 03:50 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends SMFL vs. BIOR, PXMD, BDRX, PRFX, TCBP, TFFP, SRNE, BLPH, SEEL, and NEXIShould you be buying Smart for Life stock or one of its competitors? The main competitors of Smart for Life include Biora Therapeutics (BIOR), PaxMedica (PXMD), Biodexa Pharmaceuticals (BDRX), PainReform (PRFX), TC Biopharm (TCBP), TFF Pharmaceuticals (TFFP), Sorrento Therapeutics (SRNE), Bellerophon Therapeutics (BLPH), Seelos Therapeutics (SEEL), and NexImmune (NEXI). These companies are all part of the "pharmaceutical products" industry. Smart for Life vs. Biora Therapeutics PaxMedica Biodexa Pharmaceuticals PainReform TC Biopharm TFF Pharmaceuticals Sorrento Therapeutics Bellerophon Therapeutics Seelos Therapeutics NexImmune Smart for Life (NASDAQ:SMFL) and Biora Therapeutics (NASDAQ:BIOR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their risk, earnings, community ranking, media sentiment, profitability, dividends, valuation, analyst recommendations and institutional ownership. Is SMFL or BIOR more profitable? Company Net Margins Return on Equity Return on Assets Smart for LifeN/A N/A N/A Biora Therapeutics N/A N/A -332.47% Does the media prefer SMFL or BIOR? In the previous week, Smart for Life's average media sentiment score of 0.00 equaled Biora Therapeutics'average media sentiment score. Company Overall Sentiment Smart for Life Neutral Biora Therapeutics Neutral Do analysts rate SMFL or BIOR? Biora Therapeutics has a consensus target price of $23.00, indicating a potential upside of 14,010.43%. Given Biora Therapeutics' stronger consensus rating and higher probable upside, analysts plainly believe Biora Therapeutics is more favorable than Smart for Life.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smart for Life 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Biora Therapeutics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher earnings and valuation, SMFL or BIOR? Smart for Life has higher revenue and earnings than Biora Therapeutics. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmart for Life$8.23M0.01-$22.68MN/AN/ABiora Therapeutics$892K0.83-$124.11M-$13.04-0.01 Does the MarketBeat Community favor SMFL or BIOR? Biora Therapeutics received 7 more outperform votes than Smart for Life when rated by MarketBeat users. However, 100.00% of users gave Smart for Life an outperform vote while only 80.00% of users gave Biora Therapeutics an outperform vote. CompanyUnderperformOutperformSmart for LifeOutperform Votes1100.00% Underperform VotesNo VotesBiora TherapeuticsOutperform Votes880.00% Underperform Votes220.00% Do insiders & institutionals believe in SMFL or BIOR? 28.4% of Smart for Life shares are held by institutional investors. Comparatively, 43.7% of Biora Therapeutics shares are held by institutional investors. 31.7% of Smart for Life shares are held by insiders. Comparatively, 51.1% of Biora Therapeutics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Which has more volatility and risk, SMFL or BIOR? Smart for Life has a beta of 1.45, meaning that its share price is 45% more volatile than the S&P 500. Comparatively, Biora Therapeutics has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. SummaryBiora Therapeutics beats Smart for Life on 7 of the 12 factors compared between the two stocks. Get Smart for Life News Delivered to You Automatically Sign up to receive the latest news and ratings for SMFL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SMFL vs. The Competition Export to ExcelMetricSmart for LifeMedicinals & botanicals IndustryMedical SectorNASDAQ ExchangeMarket Cap$71,000.00$1.19B$5.40B$9.13BDividend YieldN/AN/A5.37%4.00%P/E RatioN/A35.4188.8317.53Price / Sales0.015.881,284.8780.52Price / CashN/A9.9836.6032.90Price / Book0.002.084.964.69Net Income-$22.68M-$53.10M$117.89M$224.57M7 Day PerformanceN/A-0.04%2.74%3.33%1 Month PerformanceN/A-0.64%3.63%5.33%1 Year PerformanceN/A-4.80%27.26%22.97% Smart for Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SMFLSmart for LifeN/A$0.01flatN/A-99.9%$71,000.00$8.23M0.00110Gap UpBIORBiora Therapeutics2.316 of 5 stars$0.17+10.2%$23.00+13,342.4%-98.2%$774,000.00$892,000.00-0.01120Gap DownPXMDPaxMedicaN/A$0.05-7.2%N/A-94.5%$613,000.00N/A0.002BDRXBiodexa Pharmaceuticals1.8943 of 5 stars$4.30-4.9%$200.00+4,551.2%N/A$512,000.00$83,000.000.0020Positive NewsPRFXPainReform1.541 of 5 stars$2.84-9.8%$8.00+181.7%-66.4%$412,000.00N/A-0.024Positive NewsTCBPTC Biopharm1.7276 of 5 stars$0.45+13.1%$2.40+429.8%-98.0%$299,000.00$4.76M0.0080TFFPTFF Pharmaceuticals1.3479 of 5 stars$0.07flat$44.00+67,592.3%N/A$289,000.00$-70,983.00-0.0119Positive NewsSRNESorrento TherapeuticsN/A$0.00-16.7%N/A-98.8%$276,000.00$60.32M0.00800Analyst ForecastGap DownBLPHBellerophon Therapeutics0.4268 of 5 stars$0.01-25.5%N/A-80.5%$147,000.00$5.64M-0.0120Analyst ForecastNews CoverageGap DownSEELSeelos TherapeuticsN/A$0.39-4.3%N/A-100.0%$144,000.00$2.20M0.0020Gap DownNEXINexImmuneN/A$0.10flatN/A-98.6%$140,000.00N/A-0.016Gap Up Related Companies and Tools Related Companies Biora Therapeutics Competitors PaxMedica Competitors Biodexa Pharmaceuticals Competitors PainReform Competitors TC Biopharm Competitors TFF Pharmaceuticals Competitors Sorrento Therapeutics Competitors Bellerophon Therapeutics Competitors Seelos Therapeutics Competitors NexImmune Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:SMFL) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smart for Life, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Smart for Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
